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Replication-competent feline foamy or spuma virus (FFV) vectors were constructed and functionally tested. The unmodified
FFV vector genome expressed by the strong human cytomegalovirus immediate early promoter encodes FFV particles that
were replication-competent in cell cultures. Virus derived from the cloned FFV DNA replicated and persisted in experimen-
tally infected cats similar to the FFV isolate FUV. A FFV vector partially deleted in the noncoding area of the U3 region was
used to transduce the gene for the green fluorescent protein (Gfp) into cell cultures. Gfp was expressed either by an internal
ribosomal entry site (IRES) or as C-terminal fusion protein linked to Bet that was recently shown to be essential for FFV
replication. Whereas the genetic stability of the IRES–Gfp construct was comparably low, the Bet–Gfp fusion protein was
detectable upon serial cell-free vector passages. However, genetic rearrangements also occurred leading to the concomitantINTRODUCTION
Spumaretroviruses or foamy viruses (FV) are complex
retroviruses that are considered in their natural host
(Linial, 2000, 1999; Meiering and Linial, 2001). At most, a
very loose association of feline FV (FFV) infections with
uncharacterized renal symptoms of cats has been sug-
gested (Winkler et al., 1999). Due to this apparent lack
of pathogenicity and intrinsic features of their gene ex-
pression and replication, FVs are promising candidates
as viral vectors for the targeted expression of thera-
peutic proteins (Russell and Miller, 1996; Rethwilm, 1995;
Lo¨chelt and Flu¨gel, 1995; Bodem et al., 1997; Hill et al.,
1999; Lecellier and Saib, 2000; Vassilopoulos et al.,
2001). Additional advantageous features for their utiliza-
tion as vectors are the high genetic stability of FVs, the
disease-free persistence of FVs in the infected host de-
spite a strong virus-specific immune reaction, and the
expression of FV Pol proteins from a spliced transcript
(Enssle et al., 1996; Yu et al., 1996; Bodem et al., 1996;
Schweizer et al., 1999; Winkler et al., 1999; Alke et al.,
2000). However, the complex nature of the cis-acting
RNA sequences required for marker gene transfer lo-
cated in the LTR–gag junction and the pol gene has
complicated the design of the FV vector genome (Erlwein
et al., 1998; Heinkelein et al., 1998). In addition, stable
expression of FV proteins required to generate packag-
1 To whom correspondence and reprint requests should be ad-
dressed at Abteilung Retrovirale Genexpression, Forschungsschwer-
punkt Angewandte Tumorvirologie, Deutsches Krebsforschungszen-ing cells is difficult, especially when the genetic overlap
between the vector genome and the packaging con-
structs is minimized (Heinkelein et al., 2000; Russell et
al., 2001).
Because of their apathogenicity, replication-competent
FV vectors for the expression of heterologous proteins
appear very promising. The use of such vectors also
circumvents problems associated with the generation of
packaging cells and vector genomes. Replication-com-
petent vectors have been recently constructed for the
prototypic human foamy virus (HFV) isolate (Schmidt and
Rethwilm, 1995; Nestler et al., 1997). These vectors have
not been tested in vivo, possibly because mice appear to
be not fully permissive to HFV infection (Schmidt et al.,
1997b).
In order to establish a feasible and authentic animal
model for FV-derived vectors, we characterized the mo-
lecular biology of FFV in feline cell cultures and studied
the replication, immunogenicity, and potential dissemi-
nation of FFV in experimentally infected cats (Winkler et
al., 1997, 1998, 1999; Bodem et al., 1996, 1998; Zemba et
al., 2000; Alke et al., 2000, 2001). In this report we de-
scribe a first set of replication-competent FFV vectors.
We show that FFV derived from the empty, basal vector
replicates and persists in experimentally infected cats. In
feline cell cultures, derivatives of this FFV vector effi-
ciently transduced the gene encoding the green fluores-
cent protein (Gfp); however, genetic rearrangements of
the vector genome occurred over time. Further studies
are required to optimize these vectors in order to exploit
the efficiency and applicability of FV-derived retroviralloss of marker gene expression. © 2002 Elsevier Science (USA)
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RESULTS
Construction of replication-competent FFV vector
genomes
In order to generate replication-competent FFV vectors
which can be modified in the 3-LTR downstream of the
accessory bel 2/bet genes, the authentic FFV promoter
in the 5-LTR of the infectious FFV DNA clone pFeFV-7
(Fig. 1A; Zemba et al., 2000) was substituted by the
strong cytomegalovirus immediate early (CMV-IE) pro-
moter as described under Materials and Methods (Fig.
1B). Next, the resulting clone pCF-7 was used to specif-
ically replace part of the U3 promoter sequences in the
3-LTR by a short multiple cloning site (mcs; Fig. 1C).
Since this part of the 3-LTR is used in the next genera-
tion during reverse transcription to regenerate both
LTRs, this change will subsequently be transferred to
both LTRs. U3 sequences from 308 to 725 relative to
the transcriptional start site of the LTR (Bodem et al.,
1998) directly downstream of the bet stop codon up to the
unique SphI restriction site were replaced by a short mcs
to introduce two unique restriction sites that resulted in
clone pCF-7U3 (Fig. 1C).
Infectivity and gene expression of FFV clones pCF-7
and pCF-7U3
Plasmids pCF-7 and pCF-7U3 and the parental FFV
clone pFeFV-7 were transfected into Crandell feline kid-
ney (CRFK) cells. Infectivity of the three FFV clones har-
vested 3 days after DNA transfection (p.t.) from the su-
pernatant of the cells were found to be 2  105 FFU/ml
for plasmid pFeFV-7, 6  104 FFU/ml for plasmid pCF-7,
and 1  105 FFU/ml for plasmid pCF-7U3 when as-
sayed on FAB indicator cells (Zemba et al., 2000). When
the three different FFV stocks were further propagated
for an additional 2 weeks, titers increased to about 106
FFU/ml with only marginal differences between the
clones.
In parallel, viral gene expression directed from the
different FFV DNA clones 1 (data not shown) and 3 days
p.t. was analyzed by immunoblotting (Fig. 2). Sera di-
rected against FFV Bel 1, Bet, and the Env leader protein
(Elp) and a serum from the FFV-infected cat 8014 were
used (Alke et al., 2000; Wilk et al., 2001). The pattern of
FFV Bel 1 and Bet expression and proteolytic processing
of Env, Gag, and Pol proteins (Fig. 2) was almost identical
and undistinguishable from that of cells infected with
uncloned FFV (see Zemba et al., 2000).
In summary, neither substitution of the authentic U3
promoter in the 5-LTR of the cloned FFV DNA nor the
additional deletion of a substantial part of the U3 pro-
moter (residues 308 to 725 relative to the transcrip-
tional start site) significantly affected FFV replication in
CRFK cell cultures.
Experimental infection of cats with FFV derived from
plasmid pCF-7
We then studied whether the cloned FFV genome
pCF-7 encodes virions which are capable of productively
replicating and persisting in experimentally infected cats
and compared these data with the parental, uncloned
FFV isolate FUV. For this purpose, the FFV isolate FUV
was grown in permissive feline CRFK cells and pCF-7-
derived FFV was amplified by two CRFK cell culture
passages after the initial DNA transfection. Cell culture
supernatants were harvested and cleared by low-speed
centrifugation, and FFV titers expressed as FFU per mil-
liliter using FFV-FAB titration cells were determined
(Zemba et al., 2000).
Female cats were shown to be FFV-negative by im-
munoblotting (not shown) and subsequently infected
with about 3  105 FFU of FFV isolate FUV (FFV, cats 03
and 18) and 1  106 FFU of pCF-7-derived FFV (pCF-7,
cats 20 and 9042) intramuscularly as described recently
(Alke et al., 2000). After infection, the cats did not
show any obvious sign of FFV-induced disease. At dif-
ferent time points after infection, blood samples, oral
swabs, and saliva were collected and analyzed for a
serological response against FFV and for the presence
of FFV progeny virus as described previously (Alke et al.,
2000).
The humoral immune response against uncloned and
DNA-derived FFV is comparable in experimentally
infected cats
Sera taken 9, 15, 29, 41, and 85 days after experimental
infection were assayed by immunoblot analysis for FFV-
specific IgG antibodies at a dilution of 1:500. FFV-positive
cat serum 8014 served as positive control (Alke et al.,
2000). Proteins from FFV-infected CRFK cells harvested 3
days p.i. were used as antigen. FFV-specific antibodies
from cats 18 (FFV) and 20 (pCF-7) were detected using
protein A conjugated to horseradish peroxidase. Sera
taken before FFV infection showed no specific reactivity
against FFV-infected CRFK cells. At 9 days p.i., sera from
cats infected with uncloned FFV (cat 18) and pCF-7-
derived FFV (cat 20) reacted with the FFV p48Gag (Fig. 3).
At day 15 p.i., reactivity against FFV Gag proteins p52Gag
and p48Gag was markedly increased. At about 4 weeks
p.i., antibodies against the 127-kDa Pol precursor and the
p87Pol protein comprising the PR-RT-RNase H domains
were clearly detectable (Fig. 3). Additional protein bands
were detected by the cat sera; their origin is unclear at
present. As observed in a previous study (Alke et al.,
2000), an unambiguous reactivity against FFV Env and
Bet was not detectable in cat sera using immunoblot
assays. Sera from cats 03 and 9042 yielded comparable
results (data not shown).
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FIG. 1. Schematic presentation of the different FFV clones used. In (A), the FFV genome of clone pFeFV-7 is schematically shown. FFV genes and
the LTRs subdivided into the U5, R, and U3 regions, are marked by open boxes. The FFV LTR and internal promoters are marked by rectangular
arrows. In (B), clone pCF-7 is shown that contains the strong CMV-IE promoter (CMV-IE) instead of the U3 region of the 5-LTR. Clone pCF-7U3 (C)
was derived from pCF-7 by substituting noncoding sequences of the remaining U3 region downstream of the bet gene by a short multiple cloning
site (mcs). Clone pCF–IRES–Gfp (D) contains the IRES–Gfp cassette in the mcs of the parental vector pCF-7U3. In clone pCF–Bet–Gfp (E), a linker
sequence is located between the fused Bet and Gfp coding sequences. The linker contains a protease (PR) cleavage site indicated by the arrow.
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Reisolation of FFV from experimentally infected cats
As shown in our previous study on FFV-infected cats,
virus can be reisolated from peripheral blood leukocytes
(PBLs) and oral swabs/saliva using cocultivation with
FAB-indicator cells (Alke et al., 2000). Using this tech-
nique, FFV was consistently reisolated from PBLs from
cats 03, 18, and 20 starting 9 days p.i.; cat 9042 scored
positive from day 15 through to the end of the study
(Table 1). This pattern corresponded to the detection of
FFV-specific IgG stated above. FFV reisolation from oral
swabs and saliva started to be positive at day 29 for cat
18, at day 41 for cat 03, and at day 85 for cats 9042 and
20 (Table 1).
Our present data on the FFV-specific seroreactivity
and recovery of FFV from PBLs and throat samples show
that FFV derived from cloned FFV DNA replicates in cats
and leads to a persistent infection. In particular, the
results on the replication of pCF-7-derived FFV in cats
are comparable to those obtained for uncloned FFV used
in this and a previous study and are similar to the
situation of naturally FFV-infected cats (Winkler et al.,
1998; Alke et al., 2000).
FIG. 2. Immunoblot analysis of FFV Bel 1, Bet, Env Elp, Gag, and Pol protein expression of plasmids pUC18, pFeFV-7 (wt), pCF-7, and pCF-7U3
in transfected CRFK cells. CRFK cells were lysed 3 days p.t. and cellular extracts were analyzed by immunoblotting with hyperimmune sera directed
against bacterially expressed Bel 1 and Bet and an N-terminal Env peptide (Alke et al., 2000; Wilk et al., 2001). The Env precursor was only detectable
upon longer exposure. Serum of FFV-infected cat 8014 was used in parallel. The positions of molecular mass markers are shown in kilodaltons in
the left margin; the names of the detected FFV proteins are also shown. Additional bands seen also in pUC18-transfected cells were considered
unspecific.
FIG. 3. Kinetics of the humoral FFV-specific immune response of
experimentally infected cats 20 (pCF-7 DNA-derived FFV) and 18 (FFV
isolate FUV) determined by immunoblotting. Cat sera taken at defined
time points after FFV-infection as indicated below the figure were
diluted 1:500. FFV-infected CRFK cells harvested 3 days p.i. served as
antigen. As a positive control to allow identification of FFV-specific
proteins, cat antiserum 8014 was used (last lane; Alke et al., 2000). The
positions of defined FFV proteins are marked in the right margin.
TABLE 1
Detection of FFV from PBLs and Oral Cavity Samples
of FFV- and pCF-7-Infected Cats
Cat:
Days p.i.
03, FFV-
infected
(PBL/oral)
18, FFV-
infected
(PBL/oral)
20, pCF-
7-infected
(PBL/oral)
9042,
pCF-7-
infected
(PBL/oral)
9 / / / /
15 / / / /
29 / / / /
41 / / / /
85 / / / /
98 / / / /a
139 / / / /a
Note. (), No detection of FFV by cocultivation with FFAB cells; (),
successful detection of FFV by cocultivation with FFAB cells.
a No reisolation by cocultivation with CRFK cells possible.
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Construction of chimeric FFV-Gfp vectors
Recently we reported that the FFV Bet protein is re-
quired for efficient virus replication (Alke et al., 2001). In
addition, deletion of a noncoding part of the U3 did not
affect FFV replication in cell cultures as shown in this
study. Based on these results, the gene encoding the
green fluorescent protein was inserted into the new mcs
downstream of bel 2/bet in the FFV-based vector pCF-
7U3. Initially, the internal ribosomal entry site (IRES)–
Gfp sequence from vector pTRBS-UF3 (Zolotukhin et al.,
1996) was inserted into the NotI site of pCF-7U3 result-
ing in clone pCF–IRES–Gfp (Fig. 1D). Subsequently, clone
pCF–IRES–Gfp was used to eliminate the IRES element
by fusing Gfp in-frame with Bet as specified under Ma-
terials and Methods. In the resulting Bet–Gfp clone pCF–
Bet–Gfp, a short linker sequence was inserted between
Bet and Gfp (Fig. 1E). The linker sequence contains the
efficiently utilized FFV protease cleavage site at the C
terminus of FFV Gag, allowing proteolytic processing of
the Bet–Gfp fusion protein (Pfrepper et al., 1997).
Gfp marker gene transfer
Vectors pCF–IRES–Gfp and pCF–Bet–Gfp together
with parental clone pCF-7 were transfected into 293T
cells. At 1 day p.t., Gfp autofluorescence was already
clearly detectable in pCF–IRES–Gfp- and pCF–Bet–Gfp-
transfected cells (data not shown). Two days p.t., the
cell-free supernatants were used to transduce CRFK
cells. Three days after transduction, the CRFK cells were
fixed with formaldehyde and processed for detection of
the green Gfp autofluorescence. The gentle fixation al-
lowed the parallel detection of Bet by indirect immuno-
fluorescence (IIF) using a Bet-specific primary antibody
and a red Cy-3-labeled secondary conjugate. To allow
direct quantification of the Gfp levels expressed in trans-
duced cells, the images shown in Fig. 4A were taken
under identical microscopy parameters. The Gfp
autofluorescence of the pCF–IRES–Gfp vector was ho-
mogeneously distributed in the transduced cells. Since
the Gfp expression level was moderate, an increased
sensitivity setting of the confocal microscope was re-
quired for its direct visualization (Fig. 4A1). In contrast,
Gfp fluorescence induced by vector pCF–Bet–Gfp was
significantly stronger and predominantly located in the
cytoplasm of transduced CRFK cells (Fig. 4A4). The dis-
tribution of the vector-encoded Bet–Gfp fusion protein as
determined by Gfp autofluorescence and Bet IIF (Fig. 4A6
is a merge of 4A4 and 4A5) corresponded to that of the
authentic Bet protein encoded by the vector pCF–IRES–
Gfp or expressed in FFV-infected CRFK cells (Fig. 4A2
and 4A8).
Next, we determined the ratio between the efficiency
of Gfp marker gene transfer and the viral titer using FAB
indicator cells (Zemba et al., 2000). When serial dilutions
of the cell-free supernatants from transfected 293T cells
were directly analyzed for Gfp expression in living FAB
cells, Gfp autofluorescence of vector pCF–Bet–Gfp was
unambiguously detectable at titers between 104 and 105,
whereas vector pCF–IRES–Gfp-transduced cell staining
had only a titer between 102 and 103. The lower Gfp titer
obtained with vector pCF–IRES–Gfp may be in part re-
lated to the lower Gfp expression level. Determination of
the replication competence of the vectors using FAB
indicator cells showed that vector pCF–Bet–Gfp had an
initial FAB titer of 106 FFU, close to that of the parental
pCF-7, whereas the FAB titer of pCF–IRES–Gfp was about
10-fold lower. When cell-free vector-containing superna-
tants were serially passaged on CRFK cells, a gradual
loss of Gfp marker gene transfer occurred that was more
rapid for the vector pCF–IRES–Gfp.
Genetic stability of Gfp marker gene transfer
by pCF–Bet–Gfp
To quantify the loss of marker gene transfer of vector
pCF–Bet–Gfp, we used the parallel detection of Gfp
marker gene transfer and FFV Bet expression as a
marker for FFV vector replication. The experiment was
performed as that described above except that DNA was
directly transfected into CRFK cells. Cell-free superna-
tants were transferred twice a week to fresh CRFK cells
and 3 days after each passage cells were fixed with
ice-cold methanol and processed for detection of Bet by
IIF (red) and Gfp by direct green autofluorescence.
Initially (first and second passage after vector DNA
transfection), almost all cells displayed the green Gfp
fluorescence and stained red in the Bet-specific IIF (Fig.
4B). At passage three, the pCF–Bet–Gfp vector still trans-
duced the Gfp marker gene into about 80% of the Bet-
positive cells while at passage six, only 20% of the cells
showed green and red fluorescence. Marker gene trans-
duction further decreased with time and passage.
Detection of transduced Gfp and Bet–Gfp proteins by
immunoblotting
CRFK cells transfected with the pCF–Bet–Gfp vector
expressed FFV-specific Gag and Pol proteins compara-
ble to pCF-7-transfected CRFK cells (data not shown). As
expected, vector pCF–Bet–Gfp expressed a Bet–Gfp fu-
sion protein of about 69 kDa besides two additional
Gfp-specific protein bands of 26 and 21 kDa detected
with Gfp antibodies (Fig. 5A). The 26-kDa Gfp band cor-
responds to the authentic Gfp protein and is probably
released by the FFV-PR-mediated processing at the
cleavage site placed between Bet and Gfp (Fig. 1E;
Pfrepper et al., 1997). The 21-kDa band may represent a
Gfp degradation product. Upon serial cell-free passages
of the vectors, the concentrations of the 26-kDa Gfp and
the 69-kDa Bet–Gfp proteins (passage three to eight)
decreased with the concomitant increase of a band of
about 45 kDa. This 45-kDa protein designated Bet–Gfp*
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was also detectable with a Bet-specific antiserum (Fig.
5B). Bet–Gfp* is slightly larger than the authentic Bet
protein and was probably generated by genetic rear-
rangements deleting part(s) of the authentic Bet–Gfp
fusion protein.
To substantiate this assumption, extracts of trans-
duced CRFK cells that express almost exclusively the
Bet–Gfp* protein were subjected to immunoprecipitation
with the Bet-specific antiserum. The precipitated pro-
teins were detected by immunoblotting with the Gfp-
FIG. 5. Detection and characterization of Bet–Gfp fusion proteins expressed by pCF–Bet–Gfp. (A) Kinetics of the authentic Gfp, Bet–Gfp, and a
rearranged Bet–Gfp fusion protein, designated Bet–Gfp*, in CRFK cells serially transduced with vector pCF–Bet–Gfp. Passage numbers are shown
below the blots; the first lane contains an extract from pCF–Bet–Gfp-transfected CRFK cells. Cells were harvested 3 days after vector transduction
and regular aliquots were subjected to immunoblotting with Gfp-specific antibodies. The positions of marker proteins and the Bet–Gfp, Bet–Gfp*, and
Gfp proteins are given in the left and right margins, respectively. (B) Comparison of wt Bet and the rearranged Bet–Gfp* protein. The CRFK cell extract
from passage 8 of the pCF–Bet–Gfp kinetics shown in (A) and the lysate from FFV-infected CRFK cells were analyzed by immunoblotting with the FFV
Bet antiserum. The positions of the chimeric Bet–Gfp* and the authentic Bet proteins are marked. (C) Bet–Gfp* consists of Bet- and Gfp-specific
sequences. Extracts from Bet–Gfp*-expressing CRFK cells at passage eight (lanes 1 and 2), mock-infected (lane 3), and FFV-infected CRFK cells (lane
4) were prepared for immunoprecipitation with the FFV Bet antiserum (lanes 1, 3, and 4) or without any serum (lane 2). Precipitated proteins were
separated on protein gels together with cell extracts from pCF–Bet–Gfp-transduced CRFK cells at passage eight expressing the truncated Bet–Gfp*
(lane 5) and harvested at passage one expressing the authentic and full-length Bet–Gfp (lane 6). The full-length Bet–Gfp and the truncated Bet–Gfp*
(as marked in the right margin) were detected with the Gfp-specific antibodies. The positions of marker proteins are indicated in the left margin.
FIG. 4. Detection and localization of Gfp autofluorescence and Bet proteins by IIF. (A) CRFK cells were infected with cell culture supernatants of
293T cells transfected with vectors pCF–IRES–Gfp (panels 1 to 3), pCF–Bet–Gfp (panels 4 to 6), and wt pCF-7 DNA (panels 7 to 9). Three days p.i.,
Gfp autofluorescence (panels 1, 4, and 7) and Bet IIF (panels 2, 5, and 8) were detected. Panels 3, 6, and 9 represent the corresponding merges.
Images were taken at a magnification of 63-fold under the same conditions to allow direct comparison of expression levels resulting in the intentional
Gfp overexposure in panels 4 and 6. (B) Gradual loss of Gfp marker gene transduction by vector pCF–Bet–Gfp after serial cell-free passages (shown
in the right margin). After serial passages of vector pCF–Bet–Gfp, CRFK cells were processed for detection of Gfp autofluorescence (left images) and
Bet IIF (middle images) 3 days p.i. The right images present the corresponding merge of either fluorescence; original magnification was 40-fold.
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specific antibodies and a peroxidase-coupled secondary
antiserum (Fig. 5C). The Gfp-specific antibodies clearly
reacted with the precipitated Bet–Gfp* protein in lane 1.
This band comigrated with the late-passage Bet–Gfp*
protein from cellular extracts separated in parallel (Fig.
5C, lane 5). Immunoprecipitation of extracts from FFV-
and mock-infected CRFK cells yielded only minor unspe-
cific bands upon longer exposure (not shown). In the
reverse experiment with the Gfp-specific antibodies
used for immunoprecipitation and the Bet serum for
analysis of the precipitate, the chimeric nature of the
Bet–Gfp* protein was confirmed (data not shown).
Cells transfected with the pCF–IRES–Gfp construct
expressed FFV-specific proteins indistinguishable from
pCF-7-transfected CRFK cells (data not shown). When
Gfp-specific antibodies were used, decreasing concen-
trations of the 26-kDa Gfp protein were detectable up to
serial passage four (Fig. 6A). Concomitantly, Gfp-reactive
proteins of about 43 kDa appeared starting at the second
passage. Since these proteins apparently also reacted
with the Bet antiserum (Fig. 6B), it most likely represents
a truncated Bet–Gfp* fusion protein generated upon ge-
netic rearrangements of the vector genome similar to
that detected for the rearranged pCF–Bet–Gfp vector.
Concomitant with the loss of Gfp as determined by
autofluorescence and immunoblotting, the replication
capacity of the rearranged FFV–Gfp vectors increased as
determined by FAB reporter cells. These data support the
assumption that the Gfp vectors lost the marker gene
and phenotypically reverted to wt FFV.
DISCUSSION
In this study, we established and characterized repli-
cation-competent FFV-based retroviral vectors for the
transfer and expression of foreign genes. Most important
for application and functional tests in cats, the authentic
FFV genome (Zemba et al., 2000) expressed from the
constitutive CMV-IE promoter encodes FFV particles that
replicate and persist in experimentally infected cats in-
distinguishable from the parental uncloned FFV isolate
FUV. Minor differences in the kinetics of the virus reiso-
lation from the oral cavity of cats infected with uncloned
FFV and virus derived from cloned FFV DNA may be
related either to the small sample size used in this study
or to subtle differences between the genetically hetero-
geneous FFV virus stock and FFV derived from cloned
DNA. In cell culture, differences in virus replication were
not detectable when uncloned FFV was compared with
the authentic provirus expressed from the CMV-IE pro-
moter. Even a significant deletion in the noncoding re-
gion of the U3 part of the LTR from308 to725 relative
to the transcriptional start site did not affect FFV replica-
tion and continuous propagation of the FFV U3 mutant in
cell culture. The deletion introduced into the FFV U3
region is significantly smaller than that considered
present in the cell-culture-adapted prototypic HFV isolate
(Herchenro¨der et al., 1995; Schmidt et al., 1997a).
When the Gfp marker gene was inserted into the FFV
U3 mutant, the initial titer of the resulting FFV–Gfp vec-
tors was reduced. Vectors in which Gfp was directly
fused to the essential Bet protein exhibited only a slightly
reduced titer. Vectors that additionally contained the 680-
nt-long IRES element upstream of the Gfp cassette were
further compromised in replication efficiency.
Gfp autofluorescence of pCF–IRES–Gfp-transfected
and -transduced cells was moderate, whereas strong
Gfp staining was observed in cells expressing the Bet–
Gfp fusion protein of vector pCF–Bet–Gfp. This indicates
that the strong expression of Bet can be exploited for the
efficient intracellular synthesis of genetically engineered
Bet fusion proteins. The Bet IIFs and autofluorescence
images of Gfp-tagged Bet indicate that Bet is predomi-
nantly present in the cytosol of FFV-infected and -trans-
duced cells under steady-state conditions.
FIG. 6. Expression and detection of Gfp-specific proteins expressed by vector pCF–IRES–Gfp. Kinetics of the authentic Gfp and the rearranged
Bet–Gfp* proteins in CRFK cells serially transduced with cell-free supernatants of pCF–IRES–Gfp. The passage numbers are shown below the blots;
the first lane contains the extract from pCF-7-transfected CRFK cells. Cells were harvested 3 days after vector transduction and regular aliquots were
subjected to immunoblotting with the Gfp- (A) and Bet-specific antibodies (B). The positions of the Gfp and Bet–Gfp* proteins are indicated. Molecular
mass markers are shown in kilodaltons in the left margin.
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Whereas the parental FFV vectors pCF-7 and pCF-
7U3 were genetically stable, both Gfp vectors tended to
delete the heterologous insert. Concomitant with dele-
tion of the marker gene, the vector titers recovered al-
most to wt levels, indicating that both Gfp vectors had
phenotypically reverted to the parental vector. Some of
these rearranged vectors expressed a novel, truncated
Bet–Gfp* fusion protein that was slightly larger than Bet
still reacting with the Gfp antibodies. In order to further
characterize these rearranged genomes, PCR assays
encompassing the bet–gfp region were performed (data
not shown). Unexpectedly, sequencing of independent
amplicons did not allow detection of a deduced short-
ened Bet–Gfp* protein. Three independent clones from
rearranged pCF–Bet–Gfp vectors revealed different and
independent deletions starting in the linker sequence
between Bet and Gfp and terminating about 20 to 30 nt
upstream of the Gfp stop codon (data not shown). The
deduced Bet protein sequence from these pCF–Bet–Gfp
revertants contained 6 to 10 additional residues that
were derived from an alternative reading frame of Gfp.
Three independent amplicons from the rearranged pCF–
IRES–Gfp vector showed an almost complete deletion of
the IRES–Gfp cassette. In the rearranged IRES–Gfp vec-
tors, the authentic Bet sequence was not modified at all.
The fact that the bet gene was retained in the rearranged
genomes indicates that Bet is essential for FFV vector
replication as described previously (Alke et al., 2001).
The higher genetic stability of the Bet–Gfp fusion vec-
tor compared with the IRES–Gfp construct may be not
only related to the fact that the latter vector additionally
contained the 680-nt-long, GC-rich IRES element with a
pronounced secondary structure. In addition, it is likely
that the direct fusion of the Gfp marker gene to the
essential Bet protein enhanced the stability of the vector
by selection against random deletions that may occur in
Gfp.
Furthermore, it appears that the genetic stability and
the initial vector titers of the chimeric FFV–Gfp vectors
are inversely correlated with the size of the insert as had
been also described for other viral vectors (reviewed in
Miller, 1997). Replication-competent HFV-based vectors
have been described that exhibit genetic stability. Their
stability may be related to the fact that Bet was truncated,
allowing insertion of the foreign domains upstream of the
3-LTR; this avoided insertion into the LTR and genera-
tion of oversized genomes (Nestler et al., 1997; Schmidt
and Rethwilm, 1995). In addition, the HFV U3 LTR used is
considered to contain a substantial internal deletion
(Herchenro¨der et al., 1995; Schmidt et al., 1997a) larger
than that introduced into the FFV vector pCF-7U3.
In order to optimize replication-competent FFV vectors
for functional characterization and application in cats
(Alke et al., 2000; Bodem et al., 1997; Hatama et al., 2001),
studies on the function of Bet and the dependence on a
complete U3 region for replication in cats are required.
This may allow construction and utilization of FFV vec-
tors to express immunorelevant proteins, antigenic de-
terminants of feline pathogens, and other heterologous
proteins in cats.
MATERIALS AND METHODS
Virus and cells
The FFV strain FUV has been described previously
and was propagated in CRFK cells (Flower et al., 1985;
Winkler et al., 1997). FAB titration cells were selected and
maintained in CRFK cell medium supplemented with 500
g/ml G418 (Roche, Mannheim, Germany). The infectivity
of FFV and of cell-culture supernatant was assayed us-
ing FFV–FAB cells grown in 24-well plates (Zemba et al.,
2000). DNA transfection into CRFK cells was performed
by electroporation as described previously (Zemba et al.,
2000).
Virions were passaged every 3 or 4 days by infecting
new CRFK cells with cleared cell-free supernatants. The
medium was changed 2 h postinfection.
Construction of DNA clones
pCF-7. The human immediate early CMV promotor of
pBC12/CMV/IL-2 (Cullen, 1986) was amplified by PCR with
primers 1 (5-TAATCGGCCGAGCTTCCCATTGCATACG-3)
and 2 (5-GAAGAGCTCCCGTTCACTAAACGAGCTCTGC-3)
using Pfu DNA polymerase (Stratagene, Heidelberg) as
recommended by the supplier. Primer 1 contains a recog-
nition site for EagI (underlined). In order to ensure the
correct replication of the new chimeric virus, the C at po-
sition 676 of the CMV promotor was mutated into a G
according to the FFV-7 genome at position 2 relative to
the transcriptional start site.
By an independent PCR using pFeFV-7 as template
(Zemba et al., 2000) and primers 3 (5CGTTTAGT-
GAACGGGAGCTCTTCTCACAGAC-3) and 4 (5-CCTG-
GATTAGGTTGTAAGCC-3), a PCR product was gener-
ated which had a 3 overlap with the 5 end of the first
PCR product. Subsequently, both amplicons were fused
together and amplified with the external primers 1 and 4
leading to a chimeric construct of the CMV promotor
followed by the R- and U5-region of FFV. The vector
pFeFV-7 was digested with EagI and XhoI, which re-
sulted in the deletion of the entire 5-LTR. The product of
the fusion PCR was digested with the same enzymes
and both products were ligated.
pCF-7U3. In clone pCF-7, a region in the U3 of the
3-LTR (residues 308 to 725 relative to the transcrip-
tional start site) was deleted. In a standard PCR, primer
5 (5-CTGAGACTGGCACCAAAGG-3) and 6 (5-TACATG-
CATGCGGCCGCGGCTAGCTTCAGGCTTTCTATTCAGAG-
3) were used and pCF-7 served as template. Restriction
sites for NheI, SacII, and NotI together with the SphI site
were introduced by primer 6 (underlined sequence; mcs
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in Fig. 1C). The PCR product and the vector pCF-7 were
digested with SphI and BspEI and ligated.
pCF–IRES–Gfp. Into the new NotI site of clone pCF-
7U3, an IRES followed by the gfp gene taken from the
vector pTRBS-UF3 (Zolotukhin et al., 1996) was inserted. A
partial digestion of pTRBS-UF3 with NotI was performed
to prevent a NotI cleavage between the IRES and the gfp
gene.
pCF–Bet–Gfp. The gfp gene of pCF–IRES–Gfp was fused
in-frame to the C-terminus of bet/bel2. Two independent
PCRs were performed with primers 5 and 7 (5-
CTAGCGCTTTTACTGTATGTACCGCGGCTTCAGAGTCA-
GATGACTCAG-3) and with primers 8 (5-GTACATACAGTA-
AAAGCGCTAGCCGGTGGAATGAGCAAGGGCGAGGAAC-
3) and 9 (5-CAGTTCAAGAAGAGTAGGC-3). The stop-
codon of the bet gene was deleted. Additionally, two glycine
residues and the C-terminal protease cleavage site of the
FFV Gag protein were placed between Bet and the Gfp
protein (Fig. 1E; Pfrepper et al., 1997). The cleavage site
was framed by a SacII restriction site at the 5- and NheI
and Eco47III restriction sites at the 3-site. pCF–IRES–Gfp
served as template as defined above. Both amplicons were
fused and served as template in a subsequent PCR using
the external primers 5 and 9. The PCR product was di-
gested with BspEI and NotI and inserted into the corre-
spondingly digested plasmid pCF–IRES–Gfp resulting in
the DNA clone pCF–Bet–Gfp.
Immunoblotting and immunoprecipitation
Infected and transfected cells were harvested by lysis
in 1% SDS and the protein concentration was determined
using the DC protein assay (Bio-Rad, Munich). Identical
amounts of proteins were separated by SDS–PAGE, blot-
ted, reacted with cat serum 8014 at a dilution of 1:4000,
and detected as described previously (Alke et al., 2000).
The Gfp protein was detected using a mix of two Gfp-
specific monoclonal antibodies (Roche, Mannheim) and
an anti-mouse-IgG conjugated with peroxidase. For im-
munoblotting, cat sera were routinely diluted 1:500 and
detected by enhanced chemiluminescence (Amersham,
Freiburg, Germany).
For immunoprecipitations, cells were lysed in PBS,
supplemented with 1% (v/v) Triton X-100. Lysates were
cleared by high-speed centrifugation. Immunoprecipita-
tion using the monoclonal antibodies against Gfp or an
antiserum against the FFV Bet protein was performed in
20 mM Tris/HCl, pH 7.5, 0.3 M NaCl, 1% sodium deoxy-
cholate, 1% Triton X-100, 0.1% SDS (RIPA buffer), a pro-
tease inhibitor cocktail (Roche), and protein A–Sepha-
rose (CL-4B, Parmacia, Freiburg) or protein G–Sepha-
rose (Amersham) as described (Alke et al., 2000).
Precipitates were washed three times with RIPA buffer
and once with 10 mM Tris/HCl, pH 7.5, 0.1% NP-40.
Precipitated proteins were analyzed by immunoblotting
as described above.
Gfp fluorescence microscopy and indirect
immunofluorescence IIF
CRFK cells were grown and infected on coverslips in
cell culture dishes. Three days p.i., cells were washed in
prewarmed PBS containing 1 mM MgCl2 and fixed in
methanol containing 0.02% (w/v) EGTA for at least 1 h at
20°C. Subsequently, cells were rehydrated for 1 h in
PBS. As an alternative fixation, cells were incubated for
30 min at RT in PBS containing 5% formaldehyde,
washed 1 min in 0.1 M glycine in PBS, and finally incu-
bated for 3 min in 0.4% Triton X-100 in PBS. Staining of
FFV Bet was done with a Bet antiserum (Alke et al., 2001)
for 45 min at RT at a 1:1500 dilution in 3% BSA–PBS. After
three PBS washes, a secondary Cy3-labeled antibody
(Dianova, Hamburg, Germany) was used at a dilution of
1:1000 in PBS for 45 min at RT. Cells were washed three
times in PBS, rinsed in water, and dehydrated using 100%
ethanol. Coverslips were mounted in Fluoromount G
(Biozol, Munich, Germany) on microscopic slides.
Confocal microscopy was performed with an LSM 510
UV (Carl Zeiss, Jena, Germany) using an argon ion laser
(488-nm wavelength) and a helium neon laser (543-nm
wavelength) with the corresponding beam splitters and
barrier filters for colocalization of the Gfp fluorescence
and the FFV Bet staining with Cy3. Images were analyzed
with the Zeiss image browser program.
Experimental FFV infection of cats and sampling of
specimen
Domestic short hair cats used were 12 to 15 months
old and bred in the Central Animal Facilities of the
University of Heidelberg from a stock based on cats from
the University of Essen and Iffa Credo. Cats were housed
in groups in open kennels under quarantine and got tap
water and dry feed ad libitum. For virus inoculation and
blood sampling, cats were anesthetized using 10 mg
ketamine/kg body wt. Two cats each were infected either
with cell culture supernatant of FUV-infected CRFK cells
or with cell culture supernatant derived from pCF7-trans-
fected CRFK cells after two passages. Blood was taken
from the vena antebrachii and collected into EDTA-con-
taining blood sample vials (Sarstedt, Nu¨mbrecht, Ger-
many). Oral swabs taken with cotton-plugged sticks and
saliva aspirated with a syringe were pooled in sterile
PBS (Alke et al., 2000).
Enrichment of peripheral blood leukocytes and virus
recovery
Plasma was recovered by centrifugation at 3000 g at
RT for 15 min from whole blood. The resulting cell pellets
were completely resuspended in twice the volume of
PBS and purified by sedimentation through a cushion of
FicoLite-H as specified by the supplier (Linaris, Bettin-
gen, Germany) and used for cocultivation with permis-
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sive FFV–FAB and CRFK cells (Alke et al., 2000). Similarly,
saliva samples were cocultivated with permissive FFV–
FAB and CRFK cells as described (Alke et al., 2000).
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